| http://www.w3.org/ns/prov#value | - Mantle cell lymphoma is the most challenging lymphoma to treat because it is commonly resistant to chemotherapy in the relapsed setting, said Andre Goy, M.D., Chief of The Division of Lymphoma, The Cancer Center at Hackensack University Medical Center in Hackensack, N.J. This approval offers new hope for patients with mantle cell lymphoma who have received at least one prior therapy.
|
